Guardian Investor Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$644K Sell
11,008
-15
-0.1% -$906 0.51% 48
2014
Q4
$721K Sell
11,023
-267
-2% -$16.8K 0.57% 39
2014
Q3
$652K Sell
11,290
-526
-4% -$29.2K 0.52% 40
2014
Q2
$667K Sell
11,816
-451
-4% -$23.7K 0.51% 40
2014
Q1
$631K Sell
12,267
-438
-3% -$22.1K 0.49% 46
2013
Q4
$671K Buy
12,705
+17
+0.1% +$836 0.51% 44
2013
Q3
$568K Sell
12,688
-152
-1% -$6.74K 0.47% 46
2013
Q2
$531K Buy
+12,840
New +$562K 0.46% 50

Other funds holding ABBV

Guardian Investor Services's ABBV Position: Q1 2015 in Review

Guardian Investor Services reduced its AbbVie (ABBV) stake by 0.14% in Q1 2015, selling an estimated $906 and leaving 11,008 shares worth $644K. The position accounts for 0.51% of the portfolio, ranked #48.

Guardian Investor Services first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. The position peaked at $721K in Q4 2014. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

  • Guardian Investor Services held 11,008 shares of AbbVie worth $644K as of Q1 2015.
  • Guardian Investor Services sold 15 AbbVie shares in Q1 2015, an estimated $906.
  • AbbVie made up 0.51% of Guardian Investor Services's portfolio in Q1 2015, its #48 holding.
  • Guardian Investor Services first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
  • Guardian Investor Services's AbbVie position peaked at $721K in Q4 2014.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Guardian Investor Services's 13F filing for Q1 2015, filed 5 May 2015.